ScholarWorks@Hanyang University: Lee, Hye Soon

Detailed Information

Lee, Hye Soon (이혜순)

서울 의과대학 (DEPARTMENT OF INTERNAL MEDICINE)

Research Area: 류마티스내과

Tel 031-560-2247
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Rheumatoid arthritis:17||rheumatoid arthritis:9||Systemic lupus erythematosus:8||polymorphism:7||systemic lupus erythematosus:6||Polymorphism:5||genetic:4||Arthritis:4||fibromyalgia:3||lupus nephritis:3||metaanalysis:3||Prevalence:3||Lupus nephritis:3||rheumatoid:3||HLADRB1:3||Incidence:3||Rheumatoid:3||genetics:3||type 1 diabetes mellitus:3||Antirheumatic agents:2||Hashimoto&apos:2||disease:2||Quality of life:2||Graves&apos:2||Metaanalysis:2||Risk factors:2||quality of life:2||Treatment response:2||tacrolimus:2||Risk factor:2||RHEUMATOID ARTHRITIS:2||s thyroiditis:2||Early diagnosis:2||arthritis:2||single nucleotide polymorphism:2||genomewide association study:2||STAT4:2||lupus erythematosus:2||Etanercept:2||transcriptome:2||Safety:2||Pregnancy:2||mycophenolate mofetil:2||systemic:2||autoimmune thyroid diseases:2||Discordance:2||Family Size:1||Fatigue:1||Fibromyalgia:1||Fibromyalgia syndrome:1||Fractures:1||Frequency:1||GENETIC STUDIES:1||GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE 1:1||GWAS:1||Gastrointestinal diseases:1||Genetic risk score:1||Genetics:1||Gout:1||HAQ:1||HAQDI:1||HEPATITIS B VIRUS:1||HLADRB1*09:01:1||HLADRBI:1||HOUSEHOLD:1||Human urate transport 1:1||Hyperuricemia:1||Immune Cell Gene Expression Atlas from the University of Tokyo:1||Immunoassay:1||Individualized Medicine:1||Inflammatory Bowel Diseases:1||Infliximab:1||Interleukin18:1||Interstitial lung disease:1||Janus kinase inhibitor:1||Janus kinase inhibitors:1||Korea:1||Korean:1||Korean Health Assessment Questionnaire:1||LUPUS NEPHRITIS:1||Leptin:1||Lupus:1||Mannosebinding lectin:1||Mapping:1||Mortality:1||NITRIC OXIDE:1||OCCULT INFECTION:1||Osteoporosis:1||Outcome assessment:1||PAIN:1||POLYMORPHISM:1||PTPN22:1||PXK:1||Pain:1||Patient global assessment:1||Patient reported outcome measures:1||Patients:1||Peritonitis:1||Pharmacogenetics:1||Physician global assessment:1||Popliteal cyst:1||PostGWAS analysis:1||Productivity loss:1||Prognosis:1||Psoriatic Arthritis:1||RA:1||RHEUMATIC DISEASES:1||Radiographic progression:1||Remission:1||Review:1||Rheumatoid Arthritis:1||SEX:1||SHARED EPITOPE:1||SMOKING:1||Seropositive rheumatoid arthritis:1||Sleep:1||Smoking:1||Surfaceenhanced Raman scattering:1||Systemic Lupus Erythematosus:1||TNF inhibitors:1||TNFalpha blockers:1||TUMOR NECROSIS FACTORalpha BLOCKER:1||Tuberculous:1||Tumor necrosis factor inhibitors:1||URC102:1||Utility:1||ankylosing spondylitis:1||autoimmune diseases:1||autoimmunity:1||avascular necrosis:1||bioinformatics:1||biologic therapy:1||body mass index:1||bone erosion:1||celltypespecific:1||chromatin:1||cohort study:1||combination therapy:1||community survey:1||complete remission:1||cumulative corticosteroid:1||cyclophosphamide:1||disease activity:1||disease state:1||doseresponse relationship:1||earlyonset type 1 diabetes:1||epidemiology:1||erosion:1||ethnicity:1||fibromyalgia syndrome:1||gastrointestinal ultrasound:1||genetic heterogeneity:1||genotypephenotype association:1||hURAT1 inhibitor:1||healthcare costs:1||immune cell:1||immunogenetics:1||immunosuppressant:1||interleukin6:1||liver fibrosis:1||liver stiffness:1||methotrexate:1||microsatellite typing:1||obesity:1||ANTICITRULLINATED PROTEIN AUTOANTIBODIES:1||ossification of posterior longitudinal ligament:1||outcome:1||overactive bladder:1||pathogenesis:1||patientreported outcomes:1||predictor:1||prospective study:1||radiographic progression:1||s disease:1||sharp score:1||shear wave elastography:1||socioeconomic status:1||statistics:1||systematic review:1||therapeutic response:1||tolllike receptor:1||transient receptor potential vanilloid:1||organ involvement:1||Abatacept:1||Acquired hemophilia:1||Adalimumab:1||Adult onset Still&apos:1||Amino acid:1||Ankylosing Spondylitis:1||AntiCCP:1||AntiTNF drugs:1||Arthritis, rheumatoid:1||Asia:1||Associated factors:1||Avascular necrosis:1||Bioinformatic analysis:1||Biologic DMARDs:1||Biologic diseasemodifying antirheumatic drugs:1||Biological Markers:1||Biological therapy:1||Biologics:1||Biomarker:1||Biosimilar:1||Brainderived neurotrophic factor:1||CD8 Tcell:1||COL6A1:1||COMPLEMENTARY AND ALTERNATIVE MEDICINE:1||CYCLOPHOSPHAMIDE:1||Childbearing Decisions:1||Chronic widespread pain:1||Cohort studies:1||Comparative effectiveness research:1||Comparative effectiveness study:1||Copy number variations:1||DAS28:1||DEPRESSION:1||DMARDs:1||Disease Activity Score:1||Disease activity score:1||Disease susceptibility:1||Drug efficacy:1||EQ5D:1||Effectiveness:1||Endothelial nitric oxide synthase:1||Epaminurad:1||EuroQol EQ5D:1||Exercise:1||FIBROMYALGIA:1||

RSS_1.0 RSS_2.0 ATOM_1.0

222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE